The IgAN susceptibility loci discovered in genome-wide association studies (GWAS) were primarily from five genomic regions: the MHC region at 6p21, the DEFA locus at 8p23, the TNFSF13 locus at 17p23, the HORMAD2 locus at 22q12 and the CFH/CFHR locus at 1q32 (10 (link), 11 (link)). Thus all of the SNPs reported as top association signals in GWASs of IgAN were selected for further testing in LN. In total, 15 SNPs, including 8 SNPs within the MHC loci and seven SNPs outside the MHC region, were genotyped. In the discovery cohort from Beijing, genotyping in LN patients was performed with an Illumina Solexa HiSeq 2000 platform, and selected SNPs checked in the SLE patients without LN were genotyped using TaqMan allele discrimination assays (Applied Biosystems, Foster City, California, USA). For replicates, genotypes were determined using TaqMan allele discrimination assays (Beijing and Shanghai) or were directly retrieved from the original GWAS data (Hong Kong) (9 (link)).